Stock FA0 PEXA AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials PExA AB Deutsche Boerse AG

Equities

FA0

SE0007412374

Advanced Medical Equipment & Technology

Market Closed - Deutsche Boerse AG
Other stock markets
 14:29:01 28/06/2024 BST 		5-day change 1st Jan Change
0.0292 EUR +0.69% Intraday chart for PExA AB -5.19% -21.08%
05-15 PExA AB Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
02-21 PExA AB Reports Earnings Results for the Fourth Quarter Ended December 31, 2023 CI

Valuation

Fiscal Period: December 2018 2019 2021 2022 2023
Capitalization 1 27.59 20.67 49.97 27.23 17.5
Enterprise Value (EV) 1 19.43 18 29.26 8.976 7.902
P/E ratio -4.71 x -6.45 x -4.95 x -5.73 x -2.18 x
Yield - - - - -
Capitalization / Revenue 10.4 x 5.75 x 23.1 x 4.52 x 8.69 x
EV / Revenue 7.29 x 5.01 x 13.5 x 1.49 x 3.92 x
EV / EBITDA -3.36 x -3.03 x -3.91 x -2.31 x -0.97 x
EV / FCF -7.75 x -0.98 x -9.25 x -1.95 x -1.17 x
FCF Yield -12.9% -102% -10.8% -51.3% -85.5%
Price to Book 2.5 x 1.93 x 2.28 x 1.28 x 1.32 x
Nbr of stocks (in thousands) 9,226 9,226 34,704 42,276 42,276
Reference price 2 2.990 2.240 1.440 0.6440 0.4140
Announcement Date 06/05/19 05/05/20 05/05/23 05/05/23 08/05/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2021 2022 2023
Net sales 1 2.665 3.593 2.161 6.027 2.015
EBITDA 1 -5.788 -5.934 -7.476 -3.887 -8.155
EBIT 1 -5.871 -6.017 -7.799 -4.442 -8.519
Operating Margin -220.32% -167.47% -360.83% -73.7% -422.76%
Earnings before Tax (EBT) 1 -5.858 -6.007 -7.759 -4.305 -8.044
Net income 1 -5.858 -6.007 -7.759 -4.305 -8.044
Net margin -219.83% -167.2% -358.97% -71.43% -399.14%
EPS 2 -0.6350 -0.3473 -0.2908 -0.1125 -0.1903
Free Cash Flow 1 -2.508 -18.27 -3.162 -4.607 -6.753
FCF margin -94.12% -508.61% -146.28% -76.44% -335.12%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 06/05/19 05/05/20 05/05/23 05/05/23 08/05/24
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2021 2022 2023
Net Debt 1 - - - - -
Net Cash position 1 8.16 2.67 20.7 18.2 9.6
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 -2.51 -18.3 -3.16 -4.61 -6.75
ROE (net income / shareholders' equity) -41.9% -38.6% -45.5% -19.9% -46.6%
ROA (Net income/ Total Assets) -23.2% -21.6% -24.1% -10.8% -26.6%
Assets 1 25.28 27.83 32.25 39.69 30.23
Book Value Per Share 2 1.200 1.160 0.6300 0.5000 0.3100
Cash Flow per Share 2 0.8800 0.1500 0.6000 0.4300 0.2300
Capex - - 0.85 0.64 -
Capex / Sales - - 39.46% 10.56% -
Announcement Date 06/05/19 05/05/20 05/05/23 05/05/23 08/05/24
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Medical Diagnostic & Testing Equipment

1st Jan change Capi.
SARTORIUS AG Stock Sartorius AG
-34.27% 14.75B
QUIDELORTHO CORPORATION Stock QuidelOrtho Corporation
-54.93% 2.22B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD. Stock Inner Mongolia Furui Medical Science Co., Ltd.
+15.49% 1.82B
SHANGHAI MICROPORT EP MEDTECH CO., LTD. Stock Shanghai MicroPort EP MedTech Co., Ltd.
-14.07% 1.43B
BIOTAGE AB Stock Biotage AB
+21.99% 1.23B
REVENIO GROUP OYJ Stock Revenio Group Oyj
+1.25% 784M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD. Stock Shanghai AoHua Photoelectricity Endoscope Co., Ltd.
-35.50% 741M
CONTEC MEDICAL SYSTEMS CO.,LTD Stock Contec Medical Systems Co.,Ltd
-36.65% 723M
VAREX IMAGING CORPORATION Stock Varex Imaging Corporation
-28.15% 602M
Medical Diagnostic & Testing Equipment
  1. Stock Market
  2. Equities
  3. PEXA B Stock
  4. FA0 Stock
  5. Financials PExA AB